Future chelation monotherapy and combination therapy strategies in thalassemia and other conditions. comparison of deferiprone, deferoxamine, ICL670, GT56-252, L1NAll and starch deferoxamine polymers.

Future chelation monotherapy and combination therapy strategies in thalassemia and other conditions. comparison of deferiprone, deferoxamine, ICL670, GT56-252, L1NAll and starch deferoxamine polymers.

Item
http://www.wikidata.org/entity/Q36518462
Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromesIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesThe heart in transfusion dependent homozygous thalassaemia today--prediction, prevention and management.Ethical issues and risk/benefit assessment of iron chelation therapy: advances with deferiprone/deferoxamine combinations and concerns about the safety, efficacy and costs of deferasirox.The role of zinc, copper and iron in the pathogenesis of diabetes and diabetic complications: therapeutic effects by chelators.Cardiac function and iron chelation in thalassemia major and intermedia: a review of the underlying pathophysiology and approach to chelation management.Design of clinically useful macromolecular iron chelators.Synthesis and characterization of a triazine dendrimer that sequesters iron(III) using 12 desferrioxamine B groups.Pyridoxal isonicotinoyl hydrazone (PIH) and its analogs as protectants against anthracycline-induced cardiotoxicity.A new approach for potential combined chelation therapy using mono- and bis-hydroxypyridinones.Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells
P2860

Future chelation monotherapy and combination therapy strategies in thalassemia and other conditions. comparison of deferiprone, deferoxamine, ICL670, GT56-252, L1NAll and starch deferoxamine polymers.

Item
http://www.wikidata.org/entity/Q36518462
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Future chelation monotherapy a ...... starch deferoxamine polymers.
@ast
Future chelation monotherapy a ...... starch deferoxamine polymers.
@en
type
label
Future chelation monotherapy a ...... starch deferoxamine polymers.
@ast
Future chelation monotherapy a ...... starch deferoxamine polymers.
@en
prefLabel
Future chelation monotherapy a ...... starch deferoxamine polymers.
@ast
Future chelation monotherapy a ...... starch deferoxamine polymers.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Future chelation monotherapy a ...... starch deferoxamine polymers.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921